Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harvard Bioscience (HBIO) Interest Expenses (2016 - 2019)

Harvard Bioscience (HBIO) has disclosed Interest Expenses for 10 consecutive years, with $1.3 million as the latest value for Q3 2019.

  • On a quarterly basis, Interest Expenses fell 7.54% to $1.3 million in Q3 2019 year-over-year; TTM through Jun 2020 was $1.3 million, a 76.64% decrease, with the full-year FY2018 number at $5.4 million, up 652.73% from a year prior.
  • Interest Expenses was $1.3 million for Q3 2019 at Harvard Bioscience, down from $1.4 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.5 million in Q4 2018 to a low of $141000.0 in Q3 2016.
  • A 5-year average of $615368.4 and a median of $205000.0 in 2015 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: tumbled 30.88% in 2016, then skyrocketed 746.41% in 2018.
  • Harvard Bioscience's Interest Expenses stood at $205000.0 in 2015, then decreased by 24.88% to $154000.0 in 2016, then increased by 17.53% to $181000.0 in 2017, then surged by 746.41% to $1.5 million in 2018, then decreased by 12.01% to $1.3 million in 2019.
  • Per Business Quant, the three most recent readings for HBIO's Interest Expenses are $1.3 million (Q3 2019), $1.4 million (Q2 2019), and $1.4 million (Q1 2019).